Average Co-Inventor Count = 3.38
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sanofi-aventis (7 from 389 patents)
2. Sanofi (5 from 1,454 patents)
3. Sanofi-synthelabo (3 from 152 patents)
4. Synthelabo (1 from 252 patents)
16 patents:
1. 8835418 - Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
2. 8697883 - Cyclopenta[C]pyrrole-2-carboxylate derivatives, preparation thereof and therapeutic use thereof
3. 8680096 - Diphenyl-pyrazolopyridine derivatives, preparation thereof, and use thereof as nuclear receptor not modulators
4. 8618301 - 5-phenylpyrazolopyridine derivatives, preparation and therapeutic use thereof
5. 8546424 - Acetylene derivatives of 5-phenyl-pyrazolopyridine, preparation thereof, and therapeutic use thereof
6. 8288376 - [object Object]
7. 8143248 - Tricyclic N-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use
8. 8080547 - Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof
9. 7863279 - Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof
10. 7781477 - [object Object]
11. 7582671 - Therapeutic use of N-(1H-indolyl)-1H-indole-2-carboxamide derivatives
12. 7384969 - N-(1H-indolyl)-1H-indole-2-carboxamide derivatives, their preparation and their therapeutic use
13. 6635645 - 2,5,-diazabicyclo[2.2.1]heptane derivatives, their preparation and therapeutic uses
14. 6407095 - 1,4-diazabicylo[3,2,2]nonane derivatives, their preparation and their therapeutic application
15. 6140335 - Use of mizolastine for treating inflammatory diseases associated with